|Year : 2020 | Volume
| Issue : 1 | Page : 42-48
The effect of the body mass index on the types of urinary tract stones
Raed M Almannie1, Khalid A AL-Nasser2, Khalid M Al-Barraq2, Muaath M Alsheheli3, Hamdan H Al-Hazmi1, Saleh A Binsaleh1, Abdulaziz M Althunayan1, Mohammed A Alomar1
1 Department of Surgery, Division of Urology, College of Medicine and King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
2 College of Medicine, King Saud University, Riyadh, Saudi Arabia
3 College of Medicine, Immam University, Riyadh, Saudi Arabia
|Date of Submission||19-Nov-2018|
|Date of Acceptance||18-Sep-2019|
|Date of Web Publication||07-Nov-2019|
Dr. Raed M Almannie
Department of Surgery, Division of Urology, College of Medicine and King Saud University Medical City, King Saud University, Riyadh
| Abstract|| |
Objectives: Urinary tract stones are a common public health problem worldwide. In addition, identifying the composition of stones is important for the further metabolic evaluation of patients. We conducted this study to further correlate the relationship between body mass index (BMI) and different compositions of urinary tract stones.
Materials and Methods: A retrospective study of 433 patients who underwent urinary tract stone analysis via Fourier-transform infrared spectroscopy at King Khalid University Hospital in Riyadh from May 2015 to June 2017 was performed. Their BMI at the time of stone analysis was recorded.
Results: A total of 433 stones were analyzed by the statistical data analysis software. The BMI was classified according to the WHO classification. We divided our patients into seven age groups. Most patients were between the age group of 35 and 44 years and were overweight. The incidence of calcium oxalate, carbonate apatite, and uric acid stones was higher in patients with a BMI above thirty than in patients with a lower BMI. However, cystine stones were more common in normal-weight patients.
Conclusions: In this study, we found that the incidence of certain types of stones, such as calcium oxalate, cystine, and uric acid stones, in Saudi Arabia can be predicted by BMI measurement.
Keywords: Body mass index, calcium oxalate stones, urinary tract stones, urolithiasis
|How to cite this article:|
Almannie RM, AL-Nasser KA, Al-Barraq KM, Alsheheli MM, Al-Hazmi HH, Binsaleh SA, Althunayan AM, Alomar MA. The effect of the body mass index on the types of urinary tract stones. Urol Ann 2020;12:42-8
|How to cite this URL:|
Almannie RM, AL-Nasser KA, Al-Barraq KM, Alsheheli MM, Al-Hazmi HH, Binsaleh SA, Althunayan AM, Alomar MA. The effect of the body mass index on the types of urinary tract stones. Urol Ann [serial online] 2020 [cited 2020 Jan 27];12:42-8. Available from: http://www.urologyannals.com/text.asp?2020/12/1/42/270539
| Introduction|| |
Urinary tract stones are a common public health problem worldwide. Calcium oxalate and calcium phosphate stones are the most common types, accounting for >80% of urinary tract stones. Other types of stones, including uric acid, cystine, and struvite stones, account for most of the remaining stones. The prevalence and incidence of urolithiasis vary among different countries and races and between the sexes. The lifetime incidence of urolithiasis in Middle Eastern and Western countries is 25% and 10%, respectively. However, the recurrence rates are high, reaching 50% worldwide.
The pathophysiology of urolithiasis is complicated and incompletely understood; it is affected by many interacting factors, such as genetic, metabolic, and environmental factors., Furthermore, the presence of risk factors such as obesity, diabetes, hypertension, and metabolic syndrome may promote the formation of stones in the urinary tract. Recent studies have shown that patients with increased body mass index (BMI) tend to have a higher excretion of sodium, calcium, uric acid, and citrate and a lower urinary pH than nonobese patients.
The aim of this study is to correlate BMI with specific types of urinary tract stones in Saudi Arabia and further explore this relationship. This aim was addressed by analyzing data from patients who underwent urinary tract stone analysis via Fourier-transform infrared spectroscopy (FTIR).
| Materials and Methods|| |
A retrospective study including 433 patients who underwent urinary tract stone analysis via FTIR at King Khalid University Hospital (KKUH) in Riyadh from May 2015 to June 2017 was performed.
Our data were obtained from the special biochemistry laboratory at the KKUH after obtaining Institutional Review Board approval. Data privacy was maintained throughout the entire process.
Patient demographics (age, sex, and BMI), comorbidities (hypertension, diabetes mellitus, dyslipidemia and patient-specific comorbidities and stone types were included in our data.
| Results|| |
Our data were analyzed using statistical data analysis software IBM SPSS Statistics for Windows, Version 25.0. (Armonk, NY: IBM Corp) to assess a sample of 433 patients with urolithiasis who underwent FTIR. Of the patients, 316 (73%) were male and 117 (27%) were female, for a male-to-female ratio of 2.7:1.
We classified the BMI of our patients according to the WHO classification into six groups (underweight, normal weight, overweight, Class I obesity, Class II obesity, and Class III obesity). Furthermore, we divided the patients into seven groups according to age (0–14, 15–24, 25–34, 35–44, 45–54, 55–64, and 65+). Most patients were between the ages of 35 and 44 years, accounting for 99 (22.9%) of all patients. In addition, most patients were overweight, accounting for 137 (31.6%) of all patients [Table 1].
The majority of male patients were overweight, accounting for 111 (35.1%) of the 316 male patients. Female patients in our sample were mostly classified as Class I obesity, accounting for 30 (25.6%) of the 117 female patients [Table 2].
Our study included 24 underweight patients with stones; most of these stones were carbonate apatite (45.8%), calcium oxalate (33.3%), or ammonium (16.7%) stones. In addition, we had 81 normal-weight patients with stones, which were mostly calcium oxalate (50.6%), carbonate apatite (32.1%), and cystine (12.3%) stones. We had 137 overweight patients with stones; most of these stones were calcium oxalate (61.3%), carbonate apatite (27.7%), and uric acid (7.3%) stones. We had 108 patients classified as Class I obesity with stones; most of these stones were calcium oxalate (52.8%), carbonate apatite (32.4%), and uric acid stones (10.2). We had 53 patients classified as Class II obesity with stones; most of these stones were calcium oxalate (50.9%), carbonate apatite (37.7%), and uric acid (7.5%) stones. Finally, we had a total of 30 patients classified as Class III obesity with stones; most of these stones were carbonate apatite (46.7%), calcium oxalate (33.3%), and uric acid (10%) stones [Table 3].
|Table 3: All types of stones in relation to body mass index, with the value of P|
Click here to view
We calculated the value of P for all stone types and for each type individually in relation to BMI. The valueof P for the association between overall stone type and BMI was 0.000382. Furthermore, the value of P for the association with the BMI was 0.001 for ammonium stones [Table 4], 0.03 for calcium oxalate stones [Table 5], 0.253 for carbonate apatite stones [Table 6], 0.03 for cystine stones [Table 7], and 0.395 for uric acid stones [Table 8].
|Table 4: Ammonium stones in relation to body mass index, with the value of P|
Click here to view
|Table 5: Calcium oxalate stones in relation to body mass index, with the value of P|
Click here to view
|Table 6: Carbonate apatite stones in relation to body mass index, with the value of P|
Click here to view
|Table 7: Cystine stones in relation to body mass index, with the value of P|
Click here to view
|Table 8: Uric acid stones in relation to body mass index, with the value of P|
Click here to view
Calcium oxalate stones accounted for 227 (52.4%) of all stones in our sample. Eighty-four (37%) of these stones were found in overweight patients, while 57 (25.1%) were found in patients classified as Class I obesity. Carbonate apatite stones accounted for 144 (33.3%) of all stones in our sample. Thirty-eight (26.4%) of these stones were found in overweight patients, while 35 (24.3%) were found in patients classified as Class I obesity.
We observed stone recurrence in 52 patients, which would have increased the total sample size to 485. Forty-eight cases of recurrence were an initial recurrence, and four cases were the second recurrence. However, we did not include recurrence cases in our results to avoid bias.
| Discussion|| |
Identifying the composition of the stones is a core element in the metabolic evaluation of urolithiasis. Globally, urolithiasis is considered a recurrent, painful, and common problem with major deleterious sequelae. High BMI is considered to be one cause of the global rise in the prevalence and incidence of urolithiasis among both males and females.
In our study, we found that the incidence of stones was high in overweight and obese patients.,,, Indeed, 75.7% of our patients had a BMI of 25 or higher. An increase in the incidence of stones may result from certain metabolic changes related to obesity and the pathophysiology of stone formation. This issue has been discussed in many studies, which concluded that many risk factors for stone formation were observed in obese patients and linked to some types of stones., Studies have demonstrated that obesity contributes to the excess excretion of urinary calcium, oxalate, sulfate, phosphate, sodium, and uric acid. However, the core element for stone formation is acidic urine.,
In this study, we compared the incidence of different types of stones in relation to BMI. According to our results, patients with a high BMI tended to have a higher incidence of calcium oxalate, uric acid, and carbonate apatite stones than those with a lower BMI. Calcium oxalate stones accounted for 52.4% of all stones in our study; approximately 41.4% of these stones were found in patients with a BMI above 30 and 37% were found in overweight patients. Approximately 60% of all uric acid stones were found in patients with a BMI above 30. Taylor and Curhan noted a significant association between BMI and uric acid supersaturation and formation.,,, Furthermore, obese patients are at higher risk than nonobese patients of gouty diathesis, which may further promote the formation of uric acid stones., The high concentration of uric acid may lead to a decrease in the solubility of calcium oxalate, which might be associated with the reduced inhibitory activity of glycosaminoglycans on the crystallization of calcium oxalates, eventually resulting in the formation of calcium oxalate stones.
Cystine stones generally account for 1%–2% of all kidney stones. In our study, we observed 18 cases of cystine stones, which accounted for 4.2% of all stones. Ten of the affected patients were of normal weight; these stones accounted for 55.6% of all the identified cystine stones. We could not find a clear explanation supporting this high incidence of cystine stones in normal-weight patients compared to that in patients in other BMI categories.
One of the strengths of our study is our use of FTIR for the analysis of kidney stones. FTIR has been proven to overcome many limitations associated with chemical analysis.
In addition, unlike other studies, we classified the BMI of our patients according to the WHO classification. We were also able to discuss all three classes of obesity and their association with urinary tract stones.
One of the limitations of this study is the sample size. FTIR has only recently been implemented in the KKUH and has been used on fewer than 500 stones during the short usage period of 2 years.
Another limitation of this study is that some patients had missing data. Approximately seven patients were excluded from this study for this reason.
| Conclusions|| |
Patients with a higher BMI tend to have a higher chance of having stones composed mostly of calcium oxalate, carbonate apatite, or uric acid. The value of P for the association between the overall incidence of different urinary tract stones types and BMI in this study was 0.00382, which is highly significant and supports the use of BMI as a measure for predicting the incidence of different types of stones in Saudi Arabia.
This study was supported by a grant from the College of Medicine Research Center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Alkhunaizi AM. Urinary stones in Eastern Saudi Arabia. Urol Ann 2016;8:6-9.
] [Full text]
Barnela SR, Soni SS, Saboo SS, Bhansali AS. Medical management of renal stone. Indian J Endocrinol Metab 2012;16:236-9.
Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE. Diet and risk of kidney stones in the Oxford cohort of the European prospective investigation into cancer and nutrition (EPIC). Eur J Epidemiol 2014;29:363-9.
Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, et al.
Kidney stones. Nat Rev Dis Primers 2016;2:16008.
Lieske JC, Rule AD, Krambeck AE, Williams JC, Bergstralh EJ, Mehta RA, et al.
Stone composition as a function of age and sex. Clin J Am Soc Nephrol 2014;9:2141-6.
Shadman A, Bastani B. Kidney calculi: Pathophysiology and as a systemic disorder. Iran J Kidney Dis 2017;11:180-91.
Lee SC, Kim YJ, Kim TH, Yun SJ, Lee NK, Kim WJ. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol 2008;179:570-4.
Nuttall FQ. Body mass index: Obesity, BMI, and health: A critical review. Nutr Today 2015;50:117-28.
Strohmaier WL, Wrobel BM, Schubert G. Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis. Urol Res 2012;40:171-5.
Sarica K, Altay B, Erturhan S. Effect of being overweight on stone-forming risk factors. Urology 2008;71:771-4.
Semins MJ, Shore AD, Makary MA, Magnuson T, Johns R, Matlaga BR. The association of increasing body mass index and kidney stone disease. J Urol 2010;183:571-5.
Matlaga BR. Obesity-Mild or Severe-Raises Kidney Stone Risk. Baltimore, Maryland: John Hopkins Medicine; 2010.
Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;93:S9-30.
Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, et al.
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 2004;172:159-63.
Mossetti G, Rendina D, De Filippo G, Benvenuto D, Vivona CL, Zampa G, et al.
Metabolic syndrome and nephrolithiasis: Can we hypotize a common background? Clin Cases Miner Bone Metab 2008;5:114-7.
Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis 2006;48:905-15.
Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY. Association of urinary pH with body weight in nephrolithiasis. Kidney Int 2004;65:1422-5.
Asplin JR. Obesity and urolithiasis. Adv Chronic Kidney Dis 2009;16:11-20.
Duffey BG, Pedro RN, Kriedberg C, Weiland D, Melquist J, Ikramuddin S, et al.
Lithogenic risk factors in the morbidly obese population. J Urol 2008;179:1401-6.
Ryall RL, Harnett RM, Marshall VR. The effect of monosodium urate on the capacity of urine, chondroitin sulphate and heparin to inhibit calcium oxalate crystal growth and aggregation. J Urol 1986;135:174-7.
Khan AH, Imran S, Talati J, Jafri L. Fourier transform infrared spectroscopy for analysis of kidney stones. Investig Clin Urol 2018;59:32-7.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7], [Table 8]